Toll Free: 1-888-928-9744

Stemline Therapeutics, Inc. - Product Pipeline Review - 2014

Published: Jun, 2014 | Pages: 46 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Stemline Therapeutics, Inc. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Stemline Therapeutics, Inc. - Product Pipeline Review - 2014', provides an overview of the Stemline Therapeutics, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Stemline Therapeutics, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Stemline Therapeutics, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Stemline Therapeutics, Inc.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Stemline Therapeutics, Inc.'s pipeline products

Reasons to buy

- Evaluate Stemline Therapeutics, Inc.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Stemline Therapeutics, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Stemline Therapeutics, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Stemline Therapeutics, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Stemline Therapeutics, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Stemline Therapeutics, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Stemline Therapeutics, Inc. Snapshot 5
Stemline Therapeutics, Inc. Overview 5
Key Information 5
Key Facts 5
Stemline Therapeutics, Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
Stemline Therapeutics, Inc. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Stemline Therapeutics, Inc. - Pipeline Products Glance 11
Stemline Therapeutics, Inc. - Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
Phase I Products/Combination Treatment Modalities 12
Stemline Therapeutics, Inc. - Early Stage Pipeline Products 13
Preclinical Products/Combination Treatment Modalities 13
Discovery Products/Combination Treatment Modalities 14
Stemline Therapeutics, Inc. - Drug Profiles 15
SL-401 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
SL-701 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Monoclonal Antibody Targeting CD133 For Cancer 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Monoclonal Antibody Targeting Frizzled Receptor For Cancer 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Monoclonal Antibody Targeting Glypican-3 For Cancer 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
Monoclonal Antibody Targeting Patched For Cancer 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Monoclonal Antibody Targeting Smoothened For Cancer 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Monoclonal Antibody Targeting Tie-1 Receptor For Cancer 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
SL-101 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
SL-201 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
SL-202 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
SL-301 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
SL-302 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
SL-501 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
SL-601 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
Stemline Therapeutics, Inc. - Pipeline Analysis 32
Stemline Therapeutics, Inc. - Pipeline Products by Target 32
Stemline Therapeutics, Inc. - Pipeline Products by Route of Administration 34
Stemline Therapeutics, Inc. - Pipeline Products by Molecule Type 35
Stemline Therapeutics, Inc. - Pipeline Products by Mechanism of Action 36
Stemline Therapeutics, Inc. - Recent Pipeline Updates 38
Stemline Therapeutics, Inc. - Dormant Projects 43
Stemline Therapeutics, Inc. - Locations And Subsidiaries 44
Head Office 44
Appendix 45
Methodology 45
Coverage 45
Secondary Research 45
Primary Research 45
Expert Panel Validation 45
Contact Us 46
Disclaimer 46
List of Tables
Stemline Therapeutics, Inc., Key Information 5
Stemline Therapeutics, Inc., Key Facts 5
Stemline Therapeutics, Inc. - Pipeline by Indication, 2014 7
Stemline Therapeutics, Inc. - Pipeline by Stage of Development, 2014 9
Stemline Therapeutics, Inc. - Monotherapy Products in Pipeline, 2014 10
Stemline Therapeutics, Inc. - Phase II, 2014 11
Stemline Therapeutics, Inc. - Phase I, 2014 12
Stemline Therapeutics, Inc. - Preclinical, 2014 13
Stemline Therapeutics, Inc. - Discovery, 2014 14
Stemline Therapeutics, Inc. - Pipeline by Target, 2014 33
Stemline Therapeutics, Inc. - Pipeline by Route of Administration, 2014 34
Stemline Therapeutics, Inc. - Pipeline by Molecule Type, 2014 35
Stemline Therapeutics, Inc. - Pipeline Products by Mechanism of Action, 2014 36
Stemline Therapeutics, Inc. - Recent Pipeline Updates, 2014 38
Stemline Therapeutics, Inc. - Dormant Developmental Projects,2014 43 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify